HILLSTREAM BIOPHARMA INC (HILS) Forecast, Price Target & Analyst Ratings

NASDAQ:HILS • US4327051011

Current stock price

0.2305 USD
+0.01 (+2.76%)
At close:
0.2308 USD
+0 (+0.13%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HILLSTREAM BIOPHARMA INC (HILS).

Forecast Snapshot

Consensus Price Target

Price Target
$4.08
+ 1,670.07% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 6, 2023
Period
Q3 / 2023
EPS Estimate
-$0.06
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.08
Upside
+ 1,670.07%
From current price of $0.23 to mean target of $4.08, Based on 6 analyst forecasts
Low
$4.04
Median
$4.08
High
$4.20

Price Target Revisions

1 Month
0.00%
3 Months
-20.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for HILS. The average price target is 4.08 USD. This implies a price increase of 1670.07% is expected in the next year compared to the current price of 0.2305.
The average price target has been revised downward by 20% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

HILS Current Analyst RatingHILS Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

HILS Historical Analyst RatingsHILS Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -15 -14 -13 -12 -11 -10 -9 -8 -7 -6 -5 -4 -3 -2 -1 0 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
HILS was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about HILS.
In the previous month the buy percentage consensus was at a similar level.
HILS was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-07-17Dawson JamesDowngrade Buy -> Neutral

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 6, 2023
Period
Q3 / 2023
EPS Estimate
-$0.06
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
N/A
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

HILS is expected to report earnings on 11/6/2023. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2023 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
HILS revenue by date.HILS revenue by date.
N/AN/AN/AN/A
EBITDA
YoY % growth
HILS ebitda by date.HILS ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
HILS ebit by date.HILS ebit by date.
-1.424M-1.808M
-27.00%		-3.208M
-77.40%		-6.882M
-114.52%		N/A
-9.44%		N/A
36.40%		N/A
-1.00%		N/A
-63.32%
Operating Margin
HILS operating margin by date.HILS operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
HILS eps by date.HILS eps by date.
N/AN/AN/AN/AN/A
35.90%		N/A
70.00%		N/A
33.33%		N/A
-582.60%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 23 Q4 / 23
EPS
Q2Q % growth		-0.06-0.05
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-1.734M
18.50%		-1.53M
13.39%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

HILS Yearly EPS VS EstimatesHILS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -0.2 -0.4 -0.6

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
23.24%
EPS Next 5 Year
2.99%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

HILLSTREAM BIOPHARMA INC / HILS Forecast FAQ

What is the average price target for HILLSTREAM BIOPHARMA INC (HILS) stock?

6 analysts have analysed HILS and the average price target is 4.08 USD. This implies a price increase of 1670.07% is expected in the next year compared to the current price of 0.2305.

Can you provide the upcoming earnings date for HILLSTREAM BIOPHARMA INC?

HILLSTREAM BIOPHARMA INC (HILS) will report earnings on 2023-11-06.

What are the consensus estimates for HILS stock next earnings?

The consensus EPS estimate for the next earnings of HILLSTREAM BIOPHARMA INC (HILS) is -0.06 USD and the consensus revenue estimate is 0 USD.

Can you provide the analyst count for HILLSTREAM BIOPHARMA INC stock?

The number of analysts covering HILLSTREAM BIOPHARMA INC (HILS) is 6.